Omega Healthcare Investors (NYSE:OHI) Coverage Initiated at Citigroup

Share on StockTwits

Investment analysts at Citigroup began coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $44.00 price target on the real estate investment trust’s stock. Citigroup‘s target price suggests a potential upside of 1.78% from the company’s current price.

Several other analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Wednesday, January 8th. Raymond James downgraded shares of Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a report on Monday, October 21st. Wells Fargo & Co reiterated a “hold” rating on shares of Omega Healthcare Investors in a report on Monday, December 9th. Mizuho began coverage on shares of Omega Healthcare Investors in a report on Thursday, December 19th. They set a “buy” rating and a $50.00 price objective for the company. Finally, Bank of America restated a “buy” rating and set a $44.50 price objective on shares of Omega Healthcare Investors in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus price target of $43.32.

Shares of OHI stock opened at $43.23 on Wednesday. The firm has a 50-day moving average of $42.19 and a 200-day moving average of $40.96. The company has a market cap of $9.62 billion, a P/E ratio of 26.69, a P/E/G ratio of 5.53 and a beta of 0.31. The company has a debt-to-equity ratio of 1.13, a current ratio of 3.00 and a quick ratio of 3.00. Omega Healthcare Investors has a one year low of $34.64 and a one year high of $45.01.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.63 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.10). The firm had revenue of $199.00 million during the quarter, compared to analysts’ expectations of $194.26 million. Omega Healthcare Investors had a net margin of 38.12% and a return on equity of 8.76%. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 EPS. As a group, research analysts expect that Omega Healthcare Investors will post 2.99 earnings per share for the current fiscal year.

In related news, insider Steven J. Insoft sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $44.00, for a total transaction of $2,200,000.00. Following the completion of the sale, the insider now owns 183,032 shares in the company, valued at $8,053,408. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.16% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Huntington National Bank purchased a new stake in Omega Healthcare Investors during the fourth quarter worth about $27,000. Phocas Financial Corp. bought a new position in Omega Healthcare Investors during the second quarter worth about $32,000. FTB Advisors Inc. boosted its position in Omega Healthcare Investors by 48.4% during the fourth quarter. FTB Advisors Inc. now owns 766 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 250 shares during the period. Arlington Partners LLC bought a new position in Omega Healthcare Investors during the fourth quarter worth about $38,000. Finally, Stonebridge Capital Advisors LLC bought a new position in Omega Healthcare Investors during the second quarter worth about $40,000. Institutional investors and hedge funds own 75.28% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: Understanding Analyst Recommendations

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Torchlight Energy Resources  Rating Lowered to Hold at Zacks Investment Research
Torchlight Energy Resources Rating Lowered to Hold at Zacks Investment Research
VEON  Rating Lowered to Hold at Zacks Investment Research
VEON Rating Lowered to Hold at Zacks Investment Research
Varex Imaging  Stock Rating Lowered by Zacks Investment Research
Varex Imaging Stock Rating Lowered by Zacks Investment Research
Washington Federal  Coverage Initiated at Stephens
Washington Federal Coverage Initiated at Stephens
Wave Life Sciences  Stock Rating Lowered by Zacks Investment Research
Wave Life Sciences Stock Rating Lowered by Zacks Investment Research
Medtronic  PT Raised to $127.00 at Cfra
Medtronic PT Raised to $127.00 at Cfra


© 2006-2020 Ticker Report